The epigenetics of autoimmunity
Author(s)
Bibliographic Information
The epigenetics of autoimmunity
(Translational epigenetics series, v. 5)
Academic Press, an imprint of Elsevier, c2018
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Note
Includes bibliographical references and index
Description and Table of Contents
Description
The Epigenetics of Autoimmunity covers a topic directly related to translational epigenetics. Via epigenetic mechanisms, a number of internal and external environmental risk factors, including smoking, nutrition, viral infection and the exposure to chemicals, could exert their influence on the pathogenesis of autoimmune diseases. Such factors could impact the epigenetic mechanisms, which, in turn, build relationship with the regulation of gene expression, and eventually triggering immunologic events that result in instability of immune system. Since epigenetic aberrations are known to play a key role in a long list of human diseases, the translational significance of autoimmunity epigenetics is very high.
To bridge the gap between environmental and genetic factors, over the past few years, great progress has been made in identifying detailed epigenetic mechanisms for autoimmune diseases. Furthermore, with rapid advances in technological development, high-throughput screening approaches and other novel technologies support the systematic investigations and facilitate the epigenetic identification. This book covers autoimmunity epigenetics from a disease-oriented perspective and several chapters are presented that provide advances in wide-spread disorders or diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), multiple sclerosis (MS), type 1 diabetes (T1DM), systemic sclerosis (SSc), primary Sjoegren's syndrome (pSS) and autoimmune thyroid diseases (AITDs).
These emerging epigenetic studies provide new insights into autoimmune diseases, raising great expectations among researchers and clinicians. This seminal book on this topic comprehensively covers the most recent advances in this exciting and rapidly developing new science. They might reveal not only new clinical biomarkers for diagnosis and disease progression, but also novel targets for potential epigenetic therapeutic treatment.
Table of Contents
1. The epigenetics of autoimmunity: An overview 2. Immune cell development and epigenetics 3. DNA methylation and histone modifications in autoimmunity 4. MicroRNA and T helper cell-mediated immune responses 5. Long non-coding RNAs in the immune response 6. Epigenetics of Systemic Lupus Erythematosus 7. Rheumatoid Arthritis and Epigenetics 8. Epigenetic modifications in Multiple Sclerosis pathophysiology: potential diagnostic and therapeutic applications 9. Type 1 Diabetes and Epigenetics 10. Systemic Sclerosis and Epigenetics 11. Primary Sjoegren's Syndrome and Epigenetics 12. Autoimmune Thyroid Diseases and Epigenetics 13. The Epigenetics of Primary Biliary Cholangitis 14. Immune-mediated Pulmonary Disease and Epigenetics 15. The Epigenetics of Autoimmunity and Epigenetic Drug Discovery 16. Treatment of autoimmune diseases and prevention of transplant rejection/graft-versus-host disease by regulatory T cells: The state of the art and perspectives 17. Non-coding RNA-targeted therapeutics in autoimmune diseases: from bench to bedside 18. Future Challenges and Prospects for the epigenetics of autoimmunity
by "Nielsen BookData"